Evidence map›Paper›PMID 30424545›Full record

ArticleGenes2018

miRNA Mediated Noise Making of 3'UTR Mutations in Cancer.

Wei Wu, Lingxiang Wu, Mengyan Zhu, Ziyu Wang, Min Wu, Pengping Li, Yumin Nie, Xue Lin, Jie Hu, Eskil Eskilsson and 3 more

Open access · goldAbstract read
In one paragraph

Article in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Review
  5. microRNA-mediated noise processing in cells: A fight or a game?Computational and structural biotechnology journal · 2020
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Wei WuDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. wuwei.bioinformatics@gmail.com.
Lingxiang WuDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. ecsivo@gmail.com.
Mengyan ZhuDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. zhumengyan1994@njmu.edu.cn.
Ziyu WangDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. wzy_njmu@outlook.com.
Min WuDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. biowumin@gmail.com.
Pengping LiDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. lipengping@njmu.edu.cn.
Yumin NieDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. yumin_nie@njmu.edu.cn.
Xue LinDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. xue.lin@njmu.edu.cn.
Jie HuDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. hujie@njmu.edu.cn.
Eskil EskilssonIndependent, San Francisco, CA 94952, USA. eskileskilsson@gmail.com.
Qh WangDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. wangqh@njmu.edu.cn.
Jiaofang ShaoDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. shaojf@njmu.edu.cn.
Sali LyuDepartment of Bioinformatics, Nanjing Medical University, Nanjing 211166, China. lvsali@njmu.edu.cn.
Nanjing Medical University · CNFilm Independent · US

Funding

National Natural Science Foundation of China 81572893, 81502443Natural Science Foundation of Jiangsu Province BE2017733, BK20161026, BK20180036Natural Science Foundation of the Jiangsu Higher Education Institutions of China 15KJB310009, 16KJB180022Science and Technology Development Foundation of Nanjing Medical University, Jiangsu Province, China 2016NJMUZD003, 2015NJMUZD003, 2014NJMUZD013, 2017NJMURC002, 2017NJMU007State Key Laboratory of Reproductive Medicine, China SKLRM-K201804
6 · The paper itself

Abstract

Somatic mutations in 3'-untranslated regions (3'UTR) do not alter amino acids and are considered to be silent in cancers. We found that such mutations can promote tumor progression by altering microRNA (miRNA) targeting efficiency and consequently affecting miRNA⁻mRNA interactions. We identified 67,159 somatic mutations located in the 3'UTRs of messenger RNAs (mRNAs) which can alter miRNA⁻mRNA interactions (functional somatic mutations, funcMutations), and 69.3% of these funcMutations (the degree of energy change > 12 kcal/mol) were identified to significantly promote loss of miRNA-mRNA binding. By integrating mRNA expression profiles of 21 cancer types, we found that the expression of target genes was positively correlated with the loss of absolute affinity level and negatively correlated with the gain of absolute affinity level. Functional enrichment analysis revealed that genes carrying funcMutations were significantly enriched in the MAPK and WNT signaling pathways, and analysis of regulatory modules identified eighteen miRNA modules involved with similar cellular functions. Our findings elucidate a complex relationship between miRNA, mRNA, and mutations, and suggest that 3'UTR mutations may play an important role in tumor development.

Indexed as

drug response alterationdrug targetfunctional somatic mutationgene expressionmiRNA polymorphism

Identifiers

PMID30424545
PMCPMC6267165
OpenAlexW2900979975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.